Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Return on Assets (2018 - 2025)

Historic Return on Assets for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to 0.59%.

  • Whitehawk Therapeutics' Return on Assets rose 700.0% to 0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.63% for FY2024, which is 2100.0% down from last year.
  • Whitehawk Therapeutics' Return on Assets amounted to 0.59% in Q3 2025, which was up 700.0% from 0.47% recorded in Q2 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Return on Assets peaked at 0.02% during Q1 2021, and registered a low of 1.0% during Q2 2022.
  • Over the past 5 years, Whitehawk Therapeutics' median Return on Assets value was 0.48% (recorded in 2023), while the average stood at 0.52%.
  • Per our database at Business Quant, Whitehawk Therapeutics' Return on Assets plummeted by -9800bps in 2021 and then soared by 6200bps in 2023.
  • Over the past 5 years, Whitehawk Therapeutics' Return on Assets (Quarter) stood at 0.67% in 2021, then surged by 53bps to 0.32% in 2022, then plummeted by -51bps to 0.48% in 2023, then plummeted by -69bps to 0.82% in 2024, then rose by 27bps to 0.59% in 2025.
  • Its Return on Assets stands at 0.59% for Q3 2025, versus 0.47% for Q2 2025 and 0.39% for Q1 2025.